...
首页> 外文期刊>Regulatory Toxicology and Pharmacology: RTP >Comments on the opinions published by Bergman et al. (2015) on Critical Comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals (Lamb et al., 2014)
【24h】

Comments on the opinions published by Bergman et al. (2015) on Critical Comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals (Lamb et al., 2014)

机译:对Bergman等人发表的观点的评论。 (2015)关于WHO-UNEP内分泌干扰化学科学状况的评论(Lamb等,2014)

获取原文
获取原文并翻译 | 示例
           

摘要

Recently Bergman et al. (2015) took issue with our comments (Lamb et al., 2014) on the WHO-UNEP1 report entitled the "State of the Science of Endocrine Disrupting Chemicals - 2012" (WHO 2013a). We find several key differences between their view and ours regarding the selection of studies and presentation of data related to endocrine disrupting chemicals (EDCs) under the WHO-IPCS2 definition (2002). In this response we address the factors that we think are most important: 1. the difference between hazard and risk; 2. the different approaches for hazard identification (weight of the evidence [WOE] vs. emphasizing positive findings over null results); and 3. the lack of a justification for conceptual or practical differences between EDCs and other groups of agents. (C) 2015 Elsevier Inc. All rights reserved.
机译:最近,Bergman等人。 (2015年)对我们对WHO-UNEP1报告题为“ 2012年内分泌干扰化学科学状况”(WHO 2013a)的评论(Lamb等,2014)持不同意见。在WHO-IPCS2定义(2002年)下,我们在选择与内分泌干扰化学物质(EDCs)相关的数据的研究选择和数据呈现方面,发现了他们与我们的观点之间的几个主要差异。在此回应中,我们解决了我们认为最重要的因素:1.危害与风险之间的差异; 2.危害识别的不同方法(证据权重[WOE]与强调无效结果的积极发现); 3.缺乏针对EDC与其他代理人之间的概念或实践差异的理由。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号